Catalog No.
Product Name
Application
Product Information
Citations
-
Purine Nucleoside Analog
8-Bromo-9-(β-D-xylofuranosyl) guanine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer effects are primarily attributed to the inhibition of DNA synthesis and the induction of apoptosis. This compound is a valuable tool for research applications focused on cancer therapeutics and the mechanistic study of nucleoside analogs in oncology. -
Purine Nucleoside Analog
5'-DMTr-2,2'-anhydrothymidine is a purine nucleoside analog that exhibits significant antitumor activity. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it particularly relevant for research into indolent lymphoid malignancies. This compound serves as a valuable tool in cancer research, aiding in the exploration of therapeutic strategies targeting nucleoside metabolism and cellular proliferation. -
Purine Nucleoside Analog
3′-Azido-3′-deoxy-5′-O-(triphenylmethyl)thymidine is a purine nucleoside analog that demonstrates significant antitumor activity primarily against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is useful in research applications focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
N4-Benzyloxy-5’-O-(4,4’-dimethoxytrityl)-aracytidine is a purine nucleoside analog primarily designed to interfere with DNA synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inducing apoptosis and disrupting cellular replication processes. It serves as a valuable tool in cancer research, facilitating investigations into therapeutic strategies targeting nucleoside metabolism and tumor cell proliferation. -
Purine Nucleoside Analog
1-O-Acetyl-2,3,5-tri-O-benzoyl-5(R)-C-methyl-D-ribo furanose is a purine nucleoside analog that primarily targets nucleoside metabolism pathways. It exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, through mechanisms that involve the inhibition of DNA synthesis and induction of apoptosis. This compound is valuable for research applications focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
6-Methylpurine-2’-deoxy-2’-fluoro-beta-D-arabinoriboside is a purine nucleoside analog that exerts its effects primarily through the inhibition of DNA synthesis. This compound demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies, and induces apoptosis in cancer cells. Its properties make it a valuable tool for research into cancer mechanisms and therapeutic interventions. -
Purine Nucleoside Analog
3’-O-(4,4’-Dimethoxy trityl)-2’-O-(2-methoxyethyl)-5-methyluridine is a purine nucleoside analog that exhibits significant antitumor activity. It primarily targets indolent lymphoid malignancies, functioning through mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research applications focused on the development of new anticancer therapies. -
Purine Nucleoside Analog
3’-O-(t-Butyldiphenylsilyl) thymidine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable compound for cancer research. This analog is instrumental in studying the pathways related to tumorigenesis and cell death, contributing to the development of novel therapeutic strategies. -
Purine Nucleoside Analog
(1S)-1,4-Anhydro-1-C-(2,4-difluorophenyl)-D-ribitol is a purine nucleoside analog that exhibits significant antitumor activity against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is suitable for investigating therapeutic strategies aimed at targeting specific types of lymphoid cancers. -
Purine Nucleoside Analog
5-Iodo-3’-deoxy-3’-fluorouridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is suitable for studies focusing on nucleoside metabolism and therapeutic strategies in oncology. -
Uridine Analog
4’-Azido-2’-deoxy-2’-fluoro-beta-D-arabinouridine is a uridine analog with significant research applications in the study of antiepileptic and anxiolytic effects. This compound features an azide group, enabling its use in click chemistry, specifically in copper-catalyzed azide-alkyne cycloaddition (CuAAc) and strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with alkyne-containing molecules and DBCO or BCN groups. Additionally, it serves as a valuable tool for the development of new antihypertensive agents through its innovative chemical reactivity. -
Nucleoside Metabolite
5-(5-Phospho-D-ribosylaminoformimino)-1-(5-phosphoribosyl)-imidazole-4-carboxamide is a nucleoside metabolite that plays a crucial role in the biosynthesis of nucleotides. This compound is involved in various metabolic pathways, making it valuable for research focused on nucleotide synthesis and cellular signaling processes. It can be utilized in studies examining metabolic disorders and related biochemical pathways. -
Purine Nucleoside Analog
2-Deoxyuridine is a purine nucleoside analog that primarily targets DNA synthesis mechanisms. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inhibiting DNA replication and promoting apoptosis in cancer cells. Its applications include the study of cancer biology and the development of novel therapeutic strategies. -
Thymidine Analog
2'-Deoxy-2'-fluoro-5-trifluoromethyl-arabinouridine is a thymidine analog that interferes with DNA replication. This compound exhibits insertional activity, enabling it to integrate into newly synthesized DNA strands. It is valuable for labeling cells and tracking DNA synthesis in various biological research applications. -
Purine Nucleoside Analog
1,2-O-Isopropylidene-5-O-p-toluoyl-a-D-xylofuranose is a purine nucleoside analog that exhibits significant antitumor activity against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable compound for cancer research. This reagent is suitable for studies focused on understanding the effects of nucleoside analogs in tumor cell biology. -
Purine Nucleoside Analog
2′,3′,5′-Tri-O-acetyl-6-chloroguanosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms involve inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is useful for investigations into the molecular pathways of tumorigenesis and therapeutic resistance. -
Purine Nucleoside Analog
4’,5’-Didehydro-5’-deoxy thymidine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is useful for exploring therapeutic strategies and mechanisms involved in the treatment of various malignancies. -
Purine Nucleoside Analog
2’-beta-C-Methyl-4-thiouridine is a purine nucleoside analog exhibiting significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound can be used to explore therapeutic strategies and evaluate the cellular responses within various malignancies. -
Nucleoside Analog
3'-NH2-ddT (3′-Amino-2′,3′-dideoxythymidine) serves as a nucleoside analog for the synthesis of nucleic acids. This compound is utilized to introduce amino functionalities into oligonucleotides, allowing for enhanced binding properties and biological stability. It plays a crucial role in various areas of genetic research, including the development of therapeutic oligonucleotides and the study of nucleic acid interactions. -
Purine Nucleoside Analog
2’,3’,5’-Tri-O-benzoyl-5-iodouridine is a purine nucleoside analog known for its potent antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis. This compound serves as a valuable tool for researchers studying cancer biology and therapeutic strategies targeting nucleoside metabolism. -
Nucleoside Metabolite
Glutamylputrescine is a nucleoside metabolite that plays a critical role in cellular polyamine synthesis. It is involved in various biological processes, including cell proliferation and differentiation. This compound has potential applications in cancer research and studies related to cellular growth regulation. -
Nucleoside Metabolite
4-Guanidinobutanamide is a nucleoside metabolite that acts as a key modulator in various biochemical pathways. It has demonstrated significant biological activity in studies related to nucleoside metabolism and cellular signaling. This compound is primarily utilized in research applications focused on metabolic regulation and the investigation of nucleoside-related processes. -
Purine Nucleoside Analog
2'-Amino-2'-deoxy-β-D-arabino-5-methyl uridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is suitable for studies focusing on cellular proliferation, cancer therapies, and the underlying mechanisms of tumor development. -
Adenosine Analog
8-Allyloxyadenosine is an adenosine analog primarily targeting adenosine receptors. This compound exhibits significant biological activity as a smooth muscle vasodilator and has demonstrated potential in inhibiting cancer progression. It serves as a valuable tool in research applications focused on cardiovascular health and cancer therapy. -
Purine Nucleoside Analog
7,8-Dihydro-8-oxo-7-propargyl-3’-deoxy-3’-fluoro guanosine is a purine nucleoside analog that exhibits broad antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms include inhibition of DNA synthesis and induction of apoptosis. Additionally, this compound serves as a click chemistry reagent, incorporating an alkyne group that allows for copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules. This versatile profile makes it valuable for various biochemical research applications. -
Uridine Analog
3’-O-(t-Butyldimethylsilyl)-2’-O-(2-methoxyethyl) uridine is a uridine analog with potential applications in the study of antiepileptic effects. Research indicates that this compound may facilitate investigations into anticonvulsant and anxiolytic activities. Additionally, it serves as a valuable tool for the development of novel antihypertensive agents, offering insights into the therapeutic potential of uridine derivatives. -
Adenosine Analog
2-(4-Cyanobenzyl)thioadenosine is an adenosine analog that primarily targets adenosine receptors. This compound exhibits potent vasodilatory effects on smooth muscle, making it of interest in cardiovascular research. Additionally, it has demonstrated potential in inhibiting cancer progression, making it a valuable tool for cancer biology studies. -
Purine Nucleoside Analog
4’-C-Methyl-2-thiouridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is valuable for research applications aimed at understanding the biochemical pathways involved in cancer progression and therapeutic resistance. -
Nucleoside Analogue
Methyl 3,5-di-O-(2,4-dichlorobenzyl)-D-ribofuranoside is a ribofuranose nucleoside analogue that acts as a structural mimic of naturally occurring nucleosides. It exhibits potential biological activity by interfering with nucleic acid synthesis and cellular processes. This compound is primarily utilized in research related to antiviral drug development and studies on nucleoside transport mechanisms. -
Nucleoside Metabolite
8(R)-HPODE, or 8(R)-Hydroperoxylinoleic acid, is a nucleoside metabolite derived from the metabolic conversion of linoleic acid by the fungus Gaeumannomyces graminis. This compound plays a significant role in the study of lipid peroxidation and oxidative stress, serving as a valuable tool in research focused on cell signaling and inflammatory responses. Its biological activity is of particular interest in investigations of lipid metabolism and potential therapeutic applications in inflammatory diseases. -
Nucleoside Metabolite
5-Amino-1H-imidazole-4-carboxylic acid is a nucleoside metabolite involved in the purine biosynthesis pathway. It exhibits key biological activities associated with cellular metabolism and energy production. This compound is suitable for research applications investigating nucleic acid synthesis and the role of purines in cellular function and development. -
Purine Nucleoside Analog
5’-Deoxy-5’-furfurylamino thymidine is a purine nucleoside analog known for its broad antitumor activity, particularly against indolent lymphoid malignancies. This compound primarily functions by inhibiting DNA synthesis, leading to the induction of apoptosis in cancer cells. It serves as a valuable tool for research focused on cancer treatment and the mechanisms of action of nucleoside analogs in therapeutic applications. -
Purine Nucleoside Analog
5-(2-Amino-2-oxoethyl)uridine is a purine nucleoside analog that exerts significant antitumor activity, particularly against indolent lymphoid malignancies. Its biological mechanisms include inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is applicable in studies aimed at understanding cellular responses to nucleoside analogs and their effects on tumor progression. -
Nucleoside Metabolite
(E)-2-Methylbutanal oxime is a nucleoside metabolite derived from isoleucine via P450 enzyme catalysis. This compound exhibits potential biological activity important for studying metabolic pathways and enzyme interactions. Its utility in research includes the investigation of metabolic processes and the assessment of enzyme function in various biological systems. -
Nucleoside Metabolite
4-(L-Alanin-3-yl)-2-hydroxy-cis,cis-muconate 6-semialdehyde is a nucleoside metabolite that plays a critical role in various biochemical pathways. This compound is of interest in research involving nucleotide metabolism and related cellular processes. Its potential applications include studies on metabolic disorders and the regulation of nucleoside biosynthesis, making it a valuable tool for elucidating complex metabolic networks. -
Purine Nucleoside Analog
3’-F-3’-dG(iBu)-2’-phosphoramidite is a purine nucleoside analog primarily targeting DNA synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer effects are attributed to mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis, making it valuable for research in cancer biology and therapeutic applications. -
Purine Nucleoside Analog
3’-Deoxy-5-fluorouridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves inhibiting DNA synthesis, which subsequently leads to the induction of apoptosis in cancer cells. This compound is utilized in various research applications focused on cancer therapeutics and the study of nucleoside metabolism. -
Thymidine Analog
2’-Chlorothymidine is a thymidine analog that exhibits insertional activity towards replicated DNA. This compound facilitates the labeling of cells and the monitoring of DNA synthesis, making it a valuable tool for researchers studying cell proliferation and nucleic acid metabolism. Its application extends to various fields, including molecular biology and cancer research, where understanding DNA replication and cellular processes is critical. -
Purine Nucleoside Analog
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(naphthalen-1-yl)purine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms are primarily attributed to the inhibition of DNA synthesis and the induction of apoptosis. This compound serves as a valuable tool in cancer research, enabling the exploration of therapeutic strategies targeting nucleoside metabolism and cellular proliferation. -
Purine Nucleoside Analog
1-(3’-O-[4,4’-Dimethoxytrityl]-alpha-L-threofuranosyl)-thymine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research focused on cancer biology and the development of novel therapeutic strategies targeting lymphoid malignancies. -
Purine Nucleoside Analog
5’-Deoxy-5’-N-methylaminothymidine is a purine nucleoside analog that exhibits significant antitumor activity. It targets indolent lymphoid malignancies primarily through the inhibition of DNA synthesis and the induction of apoptosis. This compound is highly valuable for research applications focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
2’,3’,5’-Tri-O-acetyl-6-S-methyl-6-thio-guanosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer effects are primarily mediated through the inhibition of DNA synthesis and the induction of apoptosis. This compound serves as a valuable tool for research into cancer therapeutics and the mechanistic understanding of purine metabolism in malignant cells. -
Nucleoside Metabolite
L-Normetanephrine is a nucleoside metabolite that plays a critical role in the metabolism of catecholamines, influencing adrenergic signaling pathways. This compound has key applications in biochemical research, particularly in studies related to neuroendocrine function and the pathophysiology of various cardiovascular disorders. Its utilization can enhance the understanding of stress responses and related metabolic processes. -
Purine Nucleoside Analog
4-Amino-5-cyano-1-(β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine is a purine nucleoside analog that exhibits significant antitumor activity. It primarily targets indolent lymphoid malignancies through mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis. This compound serves as a valuable tool in cancer research, particularly in studying therapeutic strategies against specific malignancies. -
Nucleoside Metabolite
12(R),13(S)-Epoxy-9(S)-hydroxy-10(E)-octadecenoic acid is a nucleoside metabolite that plays a critical role in various biochemical pathways. This compound exhibits significant biological activity, influencing lipid metabolism and cellular signaling processes. It is valuable for research applications focused on metabolic regulation and the study of lipid-derived signaling molecules. -
Purine Nucleoside Analog
2’-Deoxy-2’-fluoro-5-methyl-4’-thio-a-D-arabino uridine is a purine nucleoside analog designed to interfere with nucleic acid metabolism. It exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inhibiting DNA synthesis and inducing apoptosis. This compound is valuable for cancer research, particularly in studying the mechanisms of tumor cell proliferation and potential therapeutic strategies. -
Purine Nucleoside Analog
3'-Deoxy-3'-fluoro-3-deazauridine is a purine nucleoside analog that primarily targets DNA synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inhibiting nucleic acid synthesis and inducing apoptosis. Its applications in cancer research make it a valuable tool for investigating therapeutic strategies against various malignancies. -
Purine Nucleoside Analog
2’-O-Methyl-5-hydroxymethyluridine is a purine nucleoside analog primarily involved in inhibiting DNA synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, through mechanisms such as the induction of apoptosis. Its potential applications in cancer research make it a valuable tool for studying tumor biology and therapeutic strategies. -
Purine Nucleoside Analog
3’-Deoxy-3’-α-C-methyl-N6,N6-dimethyladenosine is a purine nucleoside analog that exerts significant antitumor activity by targeting indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This reagent is essential for studies on nucleoside metabolism and therapeutic strategies in oncology. -
Purine Nucleoside Analog
2',3'-Isopropylidene-5-hydroxyuridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms of action involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is useful in studies aimed at understanding nucleoside metabolism and therapeutic interventions in oncology.
